Regulation of IL-6 in Immunity and Diseases
Abstract
Interleukin-6 (IL-6) is a prototypical cytokine with functional pleiotropy and plays an important role in host defense. When infections or tissue injuries occur, IL-6 is promptly produced by monocytes and macrophages and contributes to removal of infectious agents and restoration of damaged tissues through activation of immune, hematological, and acute-phase responses. Once stress is removed from the host, IL-6 synthesis ends, but uncontrolled excessive or persistent IL-6 production plays a pathological role in the development of various inflammatory diseases and cancers, indicating that IL-6 is a double-edged sword for the host. Thus, the proper IL-6 expression is very important for host defense and is strictly controlled by chromatin structure, transcriptional regulation, and posttranscriptional modification. Differentiation status of cells, various transcription factors, RNA-binding proteins, and microRNAs are involved in this process. Since it is assumed that dysregulation of any of these regulatory molecules may cause abnormal IL-6 expression in a particular disease, further elucidation of the factors and processes involved in IL-6 expression can be expected to facilitate to clarification of pathogenesis and to identification of novel target molecule(s) for specific diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046 · see citing works
Self-citationFishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243 · see citing works
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068 · see citing works
Self-citationInterleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,384 · see citing works
Self-citationActivation of interleukin-6 gene expression through the NF-kappa B transcription factor.
Libermann, T. A., & Baltimore, D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2327 · Cited by 1,372 · see citing works
Waage, A., Brandtzaeg, P., Halstensen, A. I., Kierulf, P., & Espevik, T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.333 · Cited by 1,175 · see citing works
Interleukin-6: from basic science to medicine--40 years in immunology.
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,083 · see citing works
Self-citationMatsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959 · see citing works
Self-citationModulation of Chromatin Structure Regulates Cytokine Gene Expression during T Cell Differentiation
Agarwal, S., & Rao, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80642-1 · Cited by 687 · see citing works
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., et al. (2009) · Nature · doi:10.1038/nature07924 · Cited by 677 · see citing works
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor
Leung, K., & Nabel, G. J. (1988) · Nature · doi:10.1038/333776a0 · Cited by 599 · see citing works
IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection
Akira, S., & Kishimoto, T. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01407.x · Cited by 531 · see citing works
Self-citationThe IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
Garbers, C., Aparicio-Siegmund, S., & Rose‐John, S. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.008 · Cited by 432 · see citing works
Post-transcriptional control of cytokine production
Anderson, P. (2008) · Nature Immunology · doi:10.1038/ni1584 · Cited by 422 · see citing works
Mino, T., Murakawa, Y., Fukao, A., Vandenbon, A., Wessels, H.-H., Ori, D., Uehata, T., Tartey, S., Akira, S., Suzuki, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.029 · Cited by 390 · see citing works
The Biology and Medical Implications of Interleukin-6
Tanaka, T., & Kishimoto, T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0022 · Cited by 376 · see citing works
Self-citationBerghe, W. V., Bosscher, K. D., Boone, E., Plaisance, S., & Haegeman, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32091 · Cited by 354 · see citing works
Nile, C. J., Read, R. C., Akil, M., Duff, G. W., & Wilson, A. G. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23758 · Cited by 338 · see citing works
Berghe, W. V., Vermeulen, L., Wilde, G. D., Bosscher, K. D., Boone, E., & Haegeman, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00412-3 · Cited by 303 · see citing works
Iwasaki, H., Takeuchi, O., Teraguchi, S., Matsushita, K., Uehata, T., Kuniyoshi, K., Satoh, T., Saitoh, T., Matsushita, M., Standley, D. M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2137 · Cited by 288 · see citing works
Yang, X., Liang, L., Zhang, X.-F., Jia, H.-L., Qin, Y., Zhu, X.-C., Gao, X.-M., Qiao, P., Zheng, Y., Sheng, Y.-Y., et al. (2013) · Hepatology · doi:10.1002/hep.26305 · Cited by 280 · see citing works
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 264 · see citing works
Self-citationScala, G., Ruocco, M. R., Ambrosino, C., Mallardo, M., Giordano, V., Baldassarre, F., Dragonetti, E., Quinto, I., & Venuta, S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.961 · Cited by 242 · see citing works
Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
Masuda, K., Ripley, B., Nishimura, R., Mino, T., Takeuchi, O., Shioi, G., Kiyonari, H., & Kishimoto, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307419110 · Cited by 226 · see citing works
Self-citationWang, Y., Lu, Y., Toh, S. T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.043 · Cited by 219 · see citing works
Rhinoviruses replicate effectively at lower airway temperatures
Papadopoulos, N. G., Sanderson, G., Hunter, J., & Johnston, S. L. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199905)58:1 · Cited by 212 · see citing works
Therapeutic uses of anti-interleukin-6 receptor antibody
Kang, S., Tanaka, T., & Kishimoto, T. (2014) · International Immunology · doi:10.1093/intimm/dxu081 · Cited by 172 · see citing works
Self-citationXiang, M. H., Birkbak, N. J., Vafaizadeh, V., Walker, S. R., Yeh, J., Liu, S., Kroll, Y., Boldin, M., Taganov, K. D., Groner, B., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004497 · Cited by 166 · see citing works
Ndlovu, M. N., Lint, C. M. V., Wesemael, K. V., Callebert, P., Chalbos, D., Haegeman, G., & Berghe, W. V. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01657-08 · Cited by 156 · see citing works
Ambrosino, C., Ruocco, M. R., Chen, X., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14883 · Cited by 119 · see citing works
A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA
Stoecklin, G., Gross, B., Ming, X., & Moroni, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206418 · Cited by 109 · see citing works
Inouye, S., Fujimoto, M., Nakamura, T., Takaki, E., Hayashida, N., Hai, T., & Nakai, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704471200 · Cited by 107 · see citing works
Epigenetic Regulation of the miR142-3p/Interleukin-6 Circuit in Glioblastoma
Chiou, G., Chien, C., Wang, M., Chen, M.-T., Yang, Y., Yu, Y., Chien, Y., Chang, Y., Shen, C., Chio, C., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.009 · Cited by 100 · see citing works
Kang, J., Pripuzova, N. S., Majerčiak, V., Kruhlak, M. J., Le, S., & Zheng, Z. (2011) · Journal of Virology · doi:10.1128/jvi.02144-10 · Cited by 76 · see citing works
Zhang, X. K., Gallant, S., Molano, I. D., Moussa, O., Ruiz, P., Spyropoulos, D. D., Watson, D. K., & Gilkeson, G. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6481 · Cited by 64 · see citing works
Hou, H., Wang, C., Sun, F., Zhao, L., Dun, A., & Sun, Z. (2015) · Inflammation Research · doi:10.1007/s00011-015-0850-9 · Cited by 55 · see citing works
Poplutz, M. K., Weßels, I., Rink, L., & Uciechowski, P. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.03.016 · Cited by 52 · see citing works
Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome
Georgiou, P. E., Maroulakou, I. G., Green, J., Dantis, P., Romano-Spica, V., Kottaridis, S. D., Lautenberger, J. A., Watson, D., Papas, T. S., Fischinger, P. J., et al. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.1.9 · Cited by 42 · see citing works
Saito, Y., Kagami, S., Sanayama, Y., Ikeda, K., Suto, A., Kashiwakuma, D., Furuta, S., Iwamoto, I., Nonaka, K., Ohara, O., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38324 · Cited by 40 · see citing works
Sato, S., Richard, M. L., Brandon, D., Buie, J. N. J., Oates, J. C., Gilkeson, G. S., & Zhang, X. K. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38818 · Cited by 40 · see citing works
Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases
Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T. (2013) · Inflammation and Regeneration · doi:10.2492/inflammregen.33.054 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Historical overview of the interleukin-6 family cytokine
Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190347 · Cited by 360 · see citing works
Self-citationInvestigating Immunomodulatory Biomaterials for Preventing the Foreign Body Response
Kim, A., Downer, M. A., Berry, C. E., Valencia, C., Fazilat, A. Z., & Griffin, M. (2023) · Bioengineering · doi:10.3390/bioengineering10121411 · Cited by 38 · see citing works
González-Castro, T. B., Tovilla-Zárate, C. A., López-Narváez, M. L., Genis-Mendoza, A. D., & Juárez-Rojop, I. E. (2021) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0265 · Cited by 21 · see citing works
- Authors
- Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T.
- Affiliations
- The University of Osaka (JP)
- Corresponding author
- Kishimoto, Tadamitsu
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer Netherlands
- Published
- 2016
- Volume
- 941
- Pages
- 79-88
- ISSN
- 0065-2598 (ISSN-L)
- 2214-8019
- OpenAlex
- W2531841653
- Semantic Scholar
- 1d10d14998545a6191e2829e87e398e7872403ae
- Cited by
- 235
- References
- 42
- Citations by year
- 2026: 25 · 2025: 30 · 2024: 30 · 2023: 23 · 2022: 36 · 2021: 41 · 2020: 29 · 2019: 14 · 2018: 3 · 2017: 4
- FWCI
- 17.38
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in experimental medicine and biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- interleukin-6, cytokine regulation, transcriptional regulation, post-transcriptional modification, chromatin structure, microRNA, RNA-binding proteins, transcription factors, monocytes, macrophages, acute phase response, inflammation, cancer, host defense
- MeSH terms
- Animals, Disease, Gene Expression Regulation, Humans, Immune System, Inflammation, Protein Processing, Post-Translational, Interleukin-6, RNA Interference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review